Amarantus Bioscience Holdings Inc (AMBS)

[betelgeuse]

Brick is correct.


LymPro, NuroPro, CTE look-out, are, each of them, massive milestones with significant market opportunity. Gerald with his colonels, is covering all bases and building multiple levels of defense in case the MANF fortress were to fall. It is called being pro-active and smart.

Remember CLSN, that had only one drug in the pipeline which failed and the stock tanked from $10 to $0.08?? Or a suite of PD drugs like preladenant (Merck), CERE-120 (Ceregene), rasagaline (ADAGIO), Stalevo (STRIDE)??? ALL FOUR TRIALS FAILED.


As promising as MANF is, AMBS is making sure that one failure shouldn't affect the company going forward.


As Gerald told me last week, "Once we achieve our unpcoming LymPro milestone, we expect there will be a number of collaborations available to the Company across the globe."

Get ready for the un-Chill.